ClassID:

169236

G01N33/56905 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses Protozoa

Recent Application in this class:
#1
20260063633
2026-03-05

Methods and Reagents for Toxoplasma Infection Diagnosis

#2
20260043803
2026-02-12

MEANS FOR DETECTING SCHISTOSOMA INFECTION

#3
20250327801
2025-10-23

SYSTEMS AND METHODS FOR AIRBORNE ENVIRONMENTAL DETECTION AND SURVEILLANCE OF PATHOGENS WITH ELECTROCHEMICAL ANALYSIS

#4
20250327800
2025-10-23

COMPOSITIONS AND METHODS FOR DETECTING LYMPHATIC FILARIASIS

#5
20250298018
2025-09-25

TEST FOR THE DETECTION OF ANTIBODIES AGAINST LEISHMANIA

#6
20250263478
2025-08-21

NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE

#7
20250199001
2025-06-19

METHODS OF DETECTION OF INTESTINAL PARASITES

#8
20250171508
2025-05-29

ANTIGENIC REGIONS FOR THE DETECTION OF ANTI-TOXOPLASMA GONDII IGM ANTIBODIES

#9
20250138007
2025-05-01

ANTIGENIC PEPTIDES AND METHODS OF USE FOR DIAGNOSIS OF CHAGAS DISEASE

#10
20250067735
2025-02-27

TREATMENT AND DIAGNOSIS OF TOXOPLASMA-ASSOCIATED DISEASE

#11
20240402189
2024-12-05

Methods and compositions for assessing antibody specificities

#12
20240353402
2024-10-24

RAPID TICK TESTER

#13
20240329042
2024-10-03

CAPTURE REAGENT FOR LATERAL FLOW IMMUNOASSAY

#14
20240295554
2024-09-05

System, method, apparatus and diagnostic test for plasmodium vivax

#15
20240142444
2024-05-02

DIAGNOSTIC METHOD FOR INFECTIOUS DISEASES

#16
20240133884
2024-04-25

COMPOSITIONS AND METHODS FOR DETECTING TRYPANOSOMA CRUZI INFECTION

#17
20240103000
2024-03-28

AUTOMATIC DEVICE FOR NON-INVASIVE MALARIA DIAGNOSIS THROUGH OPTICAL REFLECTANCE TECHNIQUES, METHODS AND USES THEREOF

#18
20240085420
2024-03-14

VIRUS-LIKE PARTICLE COMPRISING TOXOPLASMA GONDII PROTEIN AND INFLUENZA VIRUS PROTEIN, AND DIAGNOSTIC METHOD USING SAME

#19
20240069020
2024-02-29

FERROFLUID-BASED ASSAY METHODS, AND SYSTEMS FOR PARASITE EGGS OR OOCYSTS DETECTION

#20
20240044911
2024-02-08

Methods and compositions for assessing antibody specificities

#21
20240027451
2024-01-25

BIOSENSOR FOR ELECTROCHEMICAL DETECTION OF E.G. MALARIA BIOMARKERS

#22
20230400459
2023-12-14

GARGLE SPECIMEN SAMPLING

#23
20230375567
2023-11-23

METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES

#24
20230266306
2023-08-24

Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against

#25
20230243823
2023-08-03

BIOMARKER SENSOR-BASED DETECTION OF DISEASE-SPECIFIC BIOMARKERS

#26
20230135784
2023-05-04

USE OF VIRUS-LIKE PARTICLES INCLUDING TOXOPLASMA GONDII APICAL MEMBRANE ANTIGEN 1 FOR SERODIAGNOSING TOXOPLASMOSIS

#27
20230083668
2023-03-16

ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS

#28
20230080865
2023-03-16

CHIMERIC RECOMBINANT PROTEIN ENCODING EPITOPES WITH IDENTITY TO BACTERIAL, FUNGAL, PARASITE AND HUMAN METABOLIC ENZYMES INVOLVED IN PATHOGENESIS DURING SEXUALLY TRANSMITTED INFECTIONS

#29
20230045390
2023-02-09

PLASMODIUM VIVAX MALE GAMETE FUSION PROTEIN PVHAP2 AND THE PUTATIVE PROLIFERATING-CELL NUCLEOLAR ANTIGEN P120 AS RELAPSE BIOMARKERS

#30
20230003728
2023-01-05

VELVET DISEASE DETECTION DEVICE, SYSTEM AND METHOD

#31
20220409713
2022-12-29

COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS

#32
20220395564
2022-12-15

COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF BABESIOSIS

#33
20220390449
2022-12-08

NEW SEROLOGICAL MARKER FOR THE LATENT FORM OF TOXOPLASMOSIS

#34
20220341928
2022-10-27

DIAGNOSIS OF BABESIA USING BABESIA RECOMBINANT PROTEINS

#35
20220236268
2022-07-28

NOVEL SECRETED ANTIGENS FOR DIAGNOSIS OF ACTIVE BABESIA MICROTI AND BABESIA DUNCANI INFECTION IN HUMANS AND ANIMALs

#36
20220227853
2022-07-21

Neutralizing antibodies to circumsporozoite protein and their use

#37
20220034816
2022-02-03

Surface enhanced Raman spectroscopy point of care virus detection system

#38
20220002395
2022-01-06

Anti-plasmodium falciparum HRP-II antibody

#39
20210393760
2021-12-23

Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine

#40
20210208140
2021-07-08

DIAGNOSTIC METHODS FOR THE DETECTION AND QUANTIFICATION OF BLOOD-RELATED DISEASES

#41
20210188958
2021-06-24

B-cell epitope of cysteine protease inhibitor, hybridoma cell line, monoclonal antibody and uses thereof

#42
20210181190
2021-06-17

Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against

#43
20210156873
2021-05-27

Methods and compositions for assessing antibody specificities

#44
20210132063
2021-05-06

System, method, apparatus and diagnostic test for

#45
20210080459
2021-03-18

ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS

#46
20210024973
2021-01-28

METHOD FOR MICROBIAL SPECIES DETECTION, QUANTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY IDENTIFICATION

#47
20200347114
2020-11-05

MHC Peptide Complexes and Uses Thereof in Infectious Diseases

#48
20200330469
2020-10-22

Animal and human anti-malarial agents

#49
20200261561
2020-08-20

and vaccine

#50
20200209224
2020-07-02

METHODS AND APPARATUSES FOR IDENTIFYING RED BLOOD CELLS INFECTED BY PLASMODIUM

#51
20200141935
2020-05-07

SYSTEM, METHOD, APPARATUS AND DIAGNOSTIC TEST FOR PREGNANCY

#52
20200113988
2020-04-16

PLASMODIUM FALCIPARUM AND PLASMODIUM VIVAX VACCINE

#53
20200071740
2020-03-05

System for microbial species detection, quantification and antibiotic susceptibility identification

#54
20200064345
2020-02-27

METHODS FOR SCREENING INFECTIONS

#55
20200057063
2020-02-20

METHOD FOR DETECTING PRESENCE OF A THIOETHER AND KIT FOR DETECTING SAME

#56
20200056221
2020-02-20

Methods for diagnosing infectious diseases using adsorption media

#57
20200025778
2020-01-23

Blood analyzer and blood analyzing method for determining if plasmodium infection is present

#58
20190388524
2019-12-26

TREATMENT AND DETECTION OF TRYPANOSOMES

#59
20190369118
2019-12-05

Methods and compositions for assessing antibody specificities

#60
20190365766
2019-12-05

Animal and human anti-malarial agents

#61
20190343960
2019-11-14

Glycoconjugates and methods for their use

#62
20190282680
2019-09-19

Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine

#63
20190271697
2019-09-05

Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains

#64
20190256586
2019-08-22

Compositions and methods for detection of malaria biomarkers

#65
20190162726
2019-05-30

ANTI-T. CRUZI ANTIBODIES AND METHODS OF USE

#66
20190154685
2019-05-23

Diagnostic methods for the detection and quantification of blood-related diseases

#67
20190145973
2019-05-16

Method for the quantification of parasite eggs in feces

#68
20190128886
2019-05-02

ASSAYS FOR DETERMINIG THE PATHOGENCITY OF TOXOPLASMA INFECTIONS

#69
20180372742
2018-12-27

Babesia Biomarkers for Diagnostic and Screening In Vitro Diagnostic Test

#70
20180348218
2018-12-06

SEROLOGY ASSAY FOR RECENT MALARIA INFECTION

#71
20180280399
2018-10-04

Animal and human anti-trypanosomonal and anti-leishmania agents

#72
20180280398
2018-10-04

Animal and human anti-malarial agents

#73
20180231566
2018-08-16

Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

#74
20180185461
2018-07-05

TREATMENT AND DETECTION OF TRYPANOSOMES

#75
20180179274
2018-06-28

PROTEINS COMPRISING A MUTATED LAIR-1 FRAGMENT AND USES THEREOF

#76
20180143200
2018-05-24

Method for labeling specifically living microorganisms comprising the use of modified monosaccharide compounds

#77
20180128827
2018-05-10

Lateral flow assays with thermal contrast readers

#78
20180074055
2018-03-15

Method for the quantification of parasite eggs in feces

#79
20180052161
2018-02-22

BIOMARKERS FOR MALARIA DIAGNOSIS

#80
20180024148
2018-01-25

Blood based Plasmodium infection analyzer

#81
20180017557
2018-01-18

Antibodies to the surface of oocysts and methods of use thereof

#82
20180017556
2018-01-18

Modified Indirect Enzyme Linked Immunosorbent Assay Optimal for Monitoring Acute and Long Term Carrier Infections of Diverse Babesia bovis Strains

#83
20170348316
2017-12-07

Animal and human anti-malarial agents

#84
20170348315
2017-12-07

Animal and human anti-trypanosomonal and anti-leishmania agents

#85
20170336408
2017-11-23

Malaria detection

#86
20170333568
2017-11-23

Glycoconjugates and methods for their use

#87
20170312353
2017-11-02

Artificial antigen produced using partial sequence of enolase protein originated from plasmodium falciparum, and method for producing same

#88
20170276586
2017-09-28

Use of focused light scattering techniques in biological applications

#89
20170248598
2017-08-31

Recombinant JL7 antigen variants and their use for detecting Chagas disease

#90
20170248597
2017-08-31

Antigen composition for detecting Chagas disease

#91
20170234872
2017-08-17

In vivo induced toxoplasma gondii protein for application in diagnosis, vaccine and therapy

#92
20170219560
2017-08-03

MALARIA ANTIGEN SCREENING METHOD

#93
20170212112
2017-07-27

INTEGRATION OF SAMPLE SEPARATION WITH RAPID DIAGNOSTIC TESTS FOR IMPROVED SENSITIVITY

#94
20170168050
2017-06-15

DIFFERENTIAL DIAGNOSTIC METHOD AND KIT FOR INFECTIOUS AND PARASITIC DISEASES, USING FLOW CYTOMETRY

#95
20170131276
2017-05-11

Systems and methods of epitope binning and antibody profiling

#96
20170106071
2017-04-20

Multi-component-multistage malaria vaccines

#97
20170059592
2017-03-02

Blood analyzing method as well as stain solution and blood analyzer used for the same

#98
20170023568
2017-01-26

Anti-antibodies and methods of use

#99
20170023456
2017-01-26

Use of focused light scattering techniques in biological applications

#100
20160370356
2016-12-22

PAPER-BASED IMMUNOASSAY WITH POLYMERIZATION-BASED SIGNAL AMPLIFICATION

#101
20160296613
2016-10-13

Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction

#102
20160266113
2016-09-15

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

#103
20160202251
2016-07-14

VIRUS-LIKE PARTICLE FOR USE IN IMMUNOASSAY, BLOCKING AGENT FOR USE IN THE IMMUNOASSAY, AND KIT COMPRISING THE VIRUS-LIKE PARTICLE AND THE BLOCKING AGENT

#104
20160186158
2016-06-30

Vaccines comprising polypeptides for the treatment and diagnosis of leishmaniasis

#105
20160158329
2016-06-09

VACCINES COMPRISING LEISHMANIA POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS

#106
20160151379
2016-06-02

Combination therapies for malaria

#107
20160146809
2016-05-26

Peptides and methods for the detection of Leishmaniasis

#108
20160136106
2016-05-19

Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis

#109
20160084835
2016-03-24

Methods for diagnosing infectious diseases using adsorption media

#110
20160041097
2016-02-11

Blood analyzing method and blood analyzer

#111
20160031953
2016-02-04

Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof

#112
20150377911
2015-12-31

Biomarkers for chagas disease related cardiomyopathy

#113
20150338394
2015-11-26

Method for screening drugs and animal model for same

#114
20150316564
2015-11-05

Blood analyzing device for malaria analysis

#115
20150306195
2015-10-29

Hemoglobin receptor as novel vaccine for leishmaniasis

#116
20150293091
2015-10-15

Method for the quantification of parasite eggs in feces

#117
20150293090
2015-10-15

Recombinant GRA antigens and the use of same for early diagnosis of toxoplasmosis

#118
20150285796
2015-10-08

Peptide and Antibody Test Material for Detecting Both Vivax Malaria and Falciparum Malaria

#119
20150253320
2015-09-10

Methods and devices for integrating analyte extraction, concentration and detection

#120
20150216853
2015-08-06

Method of screening anti-plasmodial activity of acriflavin and acriflavin as an anti-malarial agent

#121
20150212083
2015-07-30

Anti-antibodies and methods of use

#122
20150204876
2015-07-23

Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients

#123
20150204869
2015-07-23

Lipocalin-2 as a Biomarker for Pneumococcal Infection Status and Uses Thereof

#124
20150203523
2015-07-23

Synthesis of diverse glycosylphosphatidylinositol glycans from and their application as vaccines and diagnostics

#125
20150160210
2015-06-11

COMPOSITIONS AND METHODS FOR ASSESSING GASTROINTESTINAL HEALTH

#126
20150140550
2015-05-21

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

#127
20150125482
2015-05-07

Recombinant polypeptide construct comprising circumsporozoite protein HLA class I restricted T-cell epitopes

#128
20150111201
2015-04-23

Portable rapid diagnostic test reader and methods of using the same

#129
20150072354
2015-03-12

COMPOUNDS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LEISHMANIASIS

#130
20150064691
2015-03-05

METHOD OF INTRACELLULAR INFECTIOUS AGENT DETECTION IN SPERM CELLS

#131
20150057174
2015-02-26

Differential diagnostic method and kit for infectious and parasitic diseases, using flow cytometry

#132
20150050643
2015-02-19

Blood analyzer, blood analysis method, hemolytic agent and staining agent

#133
20150017200
2015-01-15

Fusion proteins and their use in the diagnosis and treatment of leishmaniasis

#134
20140377741
2014-12-25

Use of focused light scattering techniques in biological applications

#135
20140356883
2014-12-04

Method for evaluating the sensitivity and specificity of fast malaria-diagnosis test kits

#136
20140350227
2014-11-27

Multi-fluorescent substance including novel coumarin derivative, and LED light source-based microfluorescent quantitative biosensor for diagnosis using same

#137
20140349873
2014-11-27

Methods of Producing Competitive Aptamer FRET Reagents and Assays

#138
20140335097
2014-11-13

Expression vectors for cell-surface expression of polypeptides comprising a transmembrane domain of glycophorin A

#139
20140329715
2014-11-06

Water Treatment and Monitoring

#140
20140329302
2014-11-06

Wireless based marine pathogens detection system

#141
20140322728
2014-10-30

Compositions and Methods for Assessing Gastrointestinal Health

#142
20140322240
2014-10-30

Malaria vaccine

#143
20140308697
2014-10-16

Methods and apparatuses for identifying red blood cells infected by plasmodium

#144
20140302492
2014-10-09

Method of detecting and/or quantifying an analyte in a biological sample

#145
20140296134
2014-10-02

Methods and uses for metabolic profiling for infection

#146
20140295403
2014-10-02

DETECTION OF BIOLOGICAL MOLECULES BY DIFFERENTIAL PARTITIONING OF ENZYME SUBSTRATES AND PRODUCTS

#147
20140227707
2014-08-14

Reagent patterning in capillarity-based analyzers and associated systems and methods

#148
20140220603
2014-08-07

Compositions and methods for detecting microbial infections

#149
20140179806
2014-06-26

BIOMARKERS FOR EARLY DETERMINATION OF A CRITICAL OR LIFE THREATENING RESPONSE TO ILLNESS AND/OR TREATMENT RESPONSE

#150
20140170637
2014-06-19

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

#151
20140134657
2014-05-15

Screening methods for identifying proteases inhibitors

#152
20140093530
2014-04-03

MALARIA VACCINES

#153
20140087399
2014-03-27

Assay method for peptide specific T-cells

#154
20140010816
2014-01-09

Treatment and prevention of malaria

#155
20130273086
2013-10-17

Compositions and methods for treatment, research and therapeutic applications for malaria

#156
20130244258
2013-09-19

Sensitive and specific assay for spp

#157
20130210023
2013-08-15

Nucleic acid aptamers against plasmodium lactate dehydrogenase and histidine-rich protein II and uses thereof for malaria diagnosis

#158
20130203085
2013-08-08

Antigenic structure and uses thereof for screening trypanosomiases in humans and animals

#159
20130203043
2013-08-08

Portable rapid diagnostic test reader

#160
20130196872
2013-08-01

Pathogen detection

#161
20130142829
2013-06-06

Mutant parasites for use as vaccines and platforms for screening for compounds

#162
20130012415
2013-01-10

Compositions and methods for diagnosis, prognosis and management of malaria

#163
20120316325
2012-12-13

DNA aptamer specifically binding to pLDH (plasmodium lactate dehydrogenase)

#164
20120316211
2012-12-13

Diagnostic Methods for Assessing Risk of Chagas Disease and Heart Failure

#165
20120289679
2012-11-15

Mite allergen

#166
20120282238
2012-11-08

Methods of diagnosing a plasmodium infection

#167
20120276523
2012-11-01

Liquid drop diagnostic assays

#168
20120276121
2012-11-01

Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases

#169
20120264161
2012-10-18

MHC peptide complexes and uses thereof in infectious diseases

#170
20120237538
2012-09-20

Recombinantly expressed CelTOS antigen and methods of use thereof

#171
20120202227
2012-08-09

genomic clones containing novel antigens useful in the diagnosis of babesiosis

#172
20120190060
2012-07-26

Microfluidic devices and methods for malaria detection

#173
20120178109
2012-07-12

Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (RPE)

#174
20120172356
2012-07-05

SERUM BIOMARKERS FOR CHAGAS DISEASE

#175
20120128725
2012-05-24

Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction

#176
20120122125
2012-05-17

Anti-antibodies and methods of use

#177
20120108538
2012-05-03

SULFATED POLYSACCHARIDES HAVING ANTIPLASMODIAL ACTIVITY AND METHODS AND PRODUCTS FOR IDENTIFYING ANTIPLASMODIAL ACTIVITY

#178
20120058488
2012-03-08

Wireless based marine pathogens detection system

#179
20120003628
2012-01-05

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

#180
20110311572
2011-12-22

Nucleotide and amino acid sequences encoding an exported protein 1 derived from and uses thereof

#181
20110311571
2011-12-22

Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor

#182
20110306062
2011-12-15

genomic clones containing novel antigens useful in the diagnosis of

#183
20110280902
2011-11-17

Compounds and methods for diagnosis and treatment of leishmaniasis

#184
20110280901
2011-11-17

Diagnosis and treatment of infection and Chagas disease

#185
20110243950
2011-10-06

MSP2 ANTIGENIC PEPTIDES AND THEIR USE

#186
20110230369
2011-09-22

METHOD FOR SCREENING COMPOUNDS FOR THEIR ABILITY TO INCREASE RIGIDITY OF RED BLOOD CELLS INFECTED BY A PROTOZOAN PARASITE OF THE GENUS PLASMODIUM, METHOD FOR FILTERING RED BLOOD CELLS, AND APPLICATION THEREOF

#187
20110229531
2011-09-22

ANTI-PROTOZOA COMPOUNDS

#188
20110189723
2011-08-04

Cell detection method, and microarray chip for use in the method

#189
20110165597
2011-07-07

Method for the screening of conserved secreted proteins

#190
20110159528
2011-06-30

Methods and materials for the detection of infection

#191
20110117120
2011-05-19

Plasmodium falciparum HLA class I restricted T-cell epitopes

#192
20110117107
2011-05-19

Compositions and methods for diagnosis, prognosis and management of malaria

#193
20110102769
2011-05-05

Malaria detection by small angle light scattering

#194
20110086369
2011-04-14

FLUORESCENT COMPOUNDS FOR THE DIAGNOSIS OF INFECTIONS, PRODUCTION METHOD, AND APPLICATIONS THEREOF

#195
20110053212
2011-03-03

Blood analyzer, blood analysis method, hemolytic agent and staining agent

#196
20110039262
2011-02-17

Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3′ UTR of SUB2 and the SUB2 serine protease

#197
20110008804
2011-01-13

ANGIOPOIETIN-1 AND -2 BIOMARKERS FOR INFECTIOUS DISEASES THAT COMPROMISE ENDOTHELIAL INTEGRITY

#198
20100304408
2010-12-02

Use of the α chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases

#199
20100291594
2010-11-18

ErbB Surface Receptor Complexes as Biomarkers

#200
20100279319
2010-11-04

Detection of plasmodium falciparum histidine-rich protein II in saliva malaria patients

#201
20100272713
2010-10-28

Genetic markers associated with endometriosis and use thereof

#202
20100260804
2010-10-14

Attenuated uracil auxotroph of an apicomplexan and use thereof

#203
20100255577
2010-10-07

USE OF A NEW ISOLATE OF NEOSPORA CANINUM FOR THE DEVELOPMENT OF DIAGNOSTIC TESTS AND FOR PREPARATION OF PRODUCTS FOR TREATMENT AND PREVENTION OF THE INFECTION CAUSED BY NEOSPORA

#204
20100247576
2010-09-30

Nucleotide and amino acid sequences encoding an exported protein 1 derived from and uses thereof

#205
20100239614
2010-09-23

Isolation and purification of merozoite protein-1vaccine

#206
20100226854
2010-09-09

MHC peptide complexes and uses thereof in infectious diseases

#207
20100222234
2010-09-02

Malaria antigen screening method

#208
20100203568
2010-08-12

Assay method for peptide specific T-cells

#209
20100196380
2010-08-05

Babesia Subtilisin

#210
20100150951
2010-06-17

PLASMODIUM FALCIPARUM ANTIGENS INDUCING PROTECTIVE ANTIBODIES

#211
20100143415
2010-06-10

Streptococcus Pneumoniae Antigens

#212
20100120067
2010-05-13

H. Meleagridis Assay

#213
20100092938
2010-04-15

Method for obtaining a cellular product from a cell or a tissue using protein-free medium

#214
20100068694
2010-03-18

Method, reagent and kit for malaria testing

#215
20100040640
2010-02-18

Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide

#216
20100040615
2010-02-18

Digalactolipidic Antigen Exposed on the Surface of Apicomplex Parasites, and Diagnostic and Therapeutic Use Thereof

#217
20100035235
2010-02-11

Use of focused light scattering techniques in biological applicationa

#218
20100028386
2010-02-04

Recombinant merozoite protein-1vaccine

#219
20100015655
2010-01-21

Methods and Kits for Detecting and Quantifying Damage Caused by a Parasite

#220
20100008924
2010-01-14

Fusion proteins and their use in the diagnosis and treatment of leishmaniasis

#221
20090325204
2009-12-31

COMPOUNDS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CHAGAS DISEASE

#222
20090324580
2009-12-31

Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases

#223
20090317841
2009-12-24

Methods and Materials for the Detection of Leishmania Infection

#224
20090232797
2009-09-17

and genes and uses thereof

#225
20090226941
2009-09-10

Detection of

#226
20090215696
2009-08-27

oocyst protein

#227
20090215087
2009-08-27

Toxoplasma gondii Oocyst Protein

#228
20090215086
2009-08-27

Biomarkers for Babesia

#229
20090203037
2009-08-13

Anti-T. Cruzi Antibodies and Methods of Use

#230
20090197347
2009-08-06

IMMUNOASSAY FOR PLASMODIUM FALCIPARUM AND ASSAY DEVICE USED THEREFOR

#231
20090196884
2009-08-06

Malaria Vaccines

#232
20090175895
2009-07-09

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA

#233
20090170124
2009-07-02

Hydrogel thin film for use as a biosensor

#234
20090170120
2009-07-02

Clinical correlates

#235
20090169554
2009-07-02

Polypeptides of and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof

#236
20090162393
2009-06-25

Vaccine composition and uses thereof

#237
20090136529
2009-05-28

Compositions and methods for treatment, research and therapeutic applications for malaria

#238
20090117602
2009-05-07

diagnostic assay device

#239
20090117600
2009-05-07

Detection of biological molecules by differential partitioning of enzyme substrates and products

#240
20090111123
2009-04-30

Compositions for detecting antibodies to and methods of uses thereof

#241
20090074783
2009-03-19

#242
20090053265
2009-02-26

Antigenic peptides and their use

#243
20090041808
2009-02-12

Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity Induction

#244
20080268466
2008-10-30

Method and device for detection

#245
20080260759
2008-10-23

Mite allergen

#246
20080248498
2008-10-09

METHODS AND COMPOSITIONS TO DIAGNOSE TRICHOMONAS INFECTION

#247
20080213795
2008-09-04

DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes

#248
20080199884
2008-08-21

Method for measuring protozoan oocyst and detecting reagent

#249
20080160606
2008-07-03

Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof

#250
20080124363
2008-05-29

Attenuated uracil auxotroph of an apicomplexan and use thereof

#251
20080107692
2008-05-08

COMPOSITIONS AND METHODS FOR THE DETECTION OF TRYPANOSOMA CRUZI INFECTION

#252
20080096232
2008-04-24

Methods for the detection and diagnosis of infection

#253
20080085523
2008-04-10

Method and device for detection

#254
20080075741
2008-03-27

Recombinant merozoite protein-1vaccine

#255
20080031878
2008-02-07

Polypeptides for the diagnosis and therapy of Leishamaniasis

#256
20080019995
2008-01-24

Diagnostic assay for infection

#257
20070275018
2007-11-29

Use of the gene NcSAG4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis

#258
20070269377
2007-11-22

Method of producing partial peptide of enolase protein from

#259
20070237794
2007-10-11

Compounds and methods for diagnosis and treatment of leishmaniasis

#260
20070178100
2007-08-02

proteome compositions and methods

#261
20070161057
2007-07-12

Methods, compositions, and kits for detecting cyrptosporidium pathogens

#262
20070148185
2007-06-28

Novel therapeutic target for protozoal diseases

#263
20070141075
2007-06-21

Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays

#264
20070134741
2007-06-14

Methods and compositions for detecting in a sample contacted with fixative

#265
20070128589
2007-06-07

Substrates, sensors, and methods for assessing conditions in females

#266
20070122853
2007-05-31

Methods and compositions for detecting larval with a cloned diagnostic antigen

#267
20070099295
2007-05-03

Methods for the determination of antibody IgG avidity

#268
20070087012
2007-04-19

Therapeutic target for protozoal diseases

#269
20070077606
2007-04-05

Methods and compositions to correlate infection with prostate cancer

#270
20070041991
2007-02-22

Babesia vaccines

#271
20070021332
2007-01-25

Helminth-derived antigens having capacity of providing protection against parasites

#272
20070015224
2007-01-18

Methods and compositions to diagnose Trichomonas infection

#273
20070014817
2007-01-18

Methods for detecting virulent , for evaluating virulence, and for screening new drugs employing the 3′UTR of SUB2 and the SUB2 serine protease

#274
20070009974
2007-01-11

Methods and compositions to diagnose infection

#275
20070003987
2007-01-04

Screening method for substance binding to merozoite surface protein-1/42

#276
20060292598
2006-12-28

Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

#277
20060292596
2006-12-28

Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

#278
20060281066
2006-12-14

Practical serological assay for the clinical diagnosis of

#279
20060275329
2006-12-07

Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic

#280
20060269618
2006-11-30

Methods and compositions for treating

#281
20060252921
2006-11-09

Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

#282
20060234317
2006-10-19

Method of screening

#283
20060233789
2006-10-19

Process for producing antigenic substance

#284
20060223137
2006-10-05

Reagent for partially lysing a cell membrane of a red blood cell, a reagent for detecting malaria infected red blood cells, and a sample analyzing method for detecting malaria infected red blood cells

#285
20060216298
2006-09-28

antigens inducing protective antibodies

#286
20060211056
2006-09-21

Leishmania antigens suitable for a diagnostic kit of Leishmania

#287
20060199175
2006-09-07

Novel field testing method and device for detection of equine protozoal myeloencephalitis

#288
20060194267
2006-08-31

Methods and kit for diagnosing tick borne illnesses

#289
20060183167
2006-08-17

Assay to screen for anti-malarials

#290
20060182769
2006-08-17

Peptide sequences specific for the hepatic stages of bearing epitopes capable of stimulating the T lymphocytes

#291
20060148010
2006-07-06

Isolation and purification of merozoite protein-142 vaccine

#292
20060105451
2006-05-18

Polynucleotide encoding a genetically engineered P30 antigen

#293
20060088892
2006-04-27

Detection of trichomonas

#294
20060088547
2006-04-27

Expression, purification and uses of a liver stage antigen 1 polypeptide

#295
20060073524
2006-04-06

Definitive diagnosis of EPM in the horse

#296
20060063185
2006-03-23

Methods for detection of pathogens in red blood cells

#297
20060046305
2006-03-02

Method and apparatus for detecting analyte with filter

#298
20060014717
2006-01-19

Therapeutic compositions for use in prophylaxis or treatment of diarrheas

#299
20050287176
2005-12-29

Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained

#300
20050260692
2005-11-24

Positive selection in the immuno-dominant surface antigen 1 (SAG1) of sarcocystis neurona, agent of EPM: potential as a diagnostic reagent and as a component of a sub-unit vaccine